Igf2bp1 appears to mediate many of its pro-oncogenic effects by binding a wide variety of cancer promoting RNAs, protecting them from degradation, enhancing their translation, and/or regulating their intracellular localization [16]. The gene discussed is IGF2BP1; the disease is cancer.